Key result
Membrane microparticles act as both biomarkers of vascular injury and active mediators of pathological processes in diseases such as diabetes, chronic kidney disease, and hypertension.
Design
Review
Authors
Loading...
Does not yet support routine microparticle testing in diabetes, CKD, or hypertension; leaves open their utility as therapeutic targets.
Microparticles are emerging as both diagnostic biomarkers and active mediators of pathology in vascular and systemic diseases.
Burger et al. (2012) conducted a review in Various diseases including diabetes, chronic kidney disease, pre-eclampsia, and hypertension. Membrane microparticles was evaluated. Membrane microparticles act as both biomarkers of vascular injury and active mediators of pathological processes in diseases such as diabetes, chronic kidney disease, and hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: